Monday's After-Hours Movers Led By Vascular Biogenics, Ultragenyx And Red Hat

Benzinga

Shares of Red Hat Inc (NYSE:RHT), which rose 2.32 percent on Monday, were down about 1 percent after hours.

Despite what the markets response might suggest, the software provider reported Q2 earnings of $0.47 per share, $0.03 above the Streets consensus estimate and the managements guidance, on revenue of $504.15 million, also atop estimates and guidance.

Continue Reading Below

Vascular Biogenics Ltd (NASDAQ:VBLT) continued to spike on Monday, gaining more than 18.25 percent, after news came out on Friday that the company will present at the European Society for Medical Oncology (ESMO). After the bell rang on Monday, the stock was up another 13 percent.

Another biopharmaceutical stock surging in Mondays after-hours was Ultragenyx Pharmaceutical Inc (NASDAQ:RARE),up more than 7 percent. The upswing seems to have been triggered by no particular news, but rather looks like a correction of the 13.94 percent decline seen during the day.

Related Link: Biotechs Are Getting Killed Because Of Hillary Clinton's Response To This Drug Price Hike

The Credit Suisse AG - VelocityShares Daily 2x VIX Short Term ETN (NASDAQ:TVIX), which replicates the returns of twice the daily performance of the S&P 500 VIX Short-Term Futures index, fell roughly 13 percent during the regular session and was down approximately 5.5 percent in after-hours trading, possibly driven by Hillary Clintons tweet about drug prices.

Disclosure: The author holds no stakes in any of the securities mentioned above.

2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.